Research suggests that psychedelics may be effective tools for treating burdensome disorders. Studies are investigating the use of psilocybin, in particular, for treatment-resistant depression, with some trials reportedly achieving their primary endpoints. However, the potential for adverse events and pharmacological interactions is also being examined.